Proteomics Intl Labs Ltd has released a press release.
First distribution agreement for PromarkerD immunoassay
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Partnership with QIMR Berghofer targets oesophageal cancer
- June 2020 Quarterly Activities Report and Appendix 4C
- PromarkerD Intellectual Property portfolio expands
- Appendix 3Y - Directors on-market purchase of shares
- Big pharma clinical study validates PromarkerD kidney test
Later from Proteomics International Laboratories
- Proteomics International raises $6m in successful Placement
- September 2020 Quarterly Activities Report and Appendix 4C
- Completion of Placement and Appendix 2A
- Proteomics receives $1.1 million in R&D tax incentive
- PromarkerD clinical assay performance results published
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories